61
Participants
Start Date
June 4, 2018
Primary Completion Date
July 31, 2023
Study Completion Date
February 28, 2027
Pacritinib
Patients receive up to 4 cycles of pacritinib before allo-SCT
BE-Antwerpen-ZNASTUIVENBERG, Antwerp
BE-Gent-UZGENT, Ghent
BE-Leuven-UZLEUVEN, Leuven
BE-Roeselare-AZDELTA, Roeselare
NL-Amsterdam-AMC, Amsterdam
NL-Amsterdam-VUMC, Amsterdam
NL-Groningen-UMCG, Groningen
NL-Maastricht-MUMC, Maastricht
NL-Nijmegen-RADBOUDUMC, Nijmegen
NL-Rotterdam-EMCDANIEL, Rotterdam
NL-Rotterdam-ERASMUSMC, Rotterdam
NL-Utrecht-UMCUTRECHT, Utrecht
Collaborators (1)
Dutch Cancer Society
OTHER
CTI BioPharma
INDUSTRY
Stichting Hemato-Oncologie voor Volwassenen Nederland
OTHER